Global Synthetic Biology Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

1. Synthetic Biology Market Overview
2. Executive Summary
3. Synthetic Biology Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis 
      3.2.1. Product Benchmarking
      3.2.2. End User profiling
      3.2.3. Patent Analysis
      3.2.3. Top 5 Financials Analysis
4. Synthetic Biology Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Synthetic Biology Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers 
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Synthetic Biology Market – Strategic Analysis
   5.1. Synthetic Biology Market - Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Product/Market Life Cycle Analysis
   5.4. Suppliers and Distributors
   5.5. Opportunities Analysis.
6. Synthetic Biology Market – By Tools
   6.1. Introduction
   6.2. Xeno-Nucleic Acid
   6.3. Chassis Organism
   6.4. Oligonucleotides
   6.5. Cloning Technology Kits
   6.6. Enzymes
   6.7. Synthetic DNA
   6.8. Synthetic Genes
   6.9. Synthetic Cells
7. Synthetic Biology Market – By Technology
   7.1. Introduction
   7.2. DNA Synthesis
   7.3. DNA Sequencing
   7.4. Computational Modelling
   7.5. Bioinformatics Technology
   7.6. Microfluidics Technology
   7.7. Nanotechnology
   7.8. Pathway Engineering
   7.9. Modular Protein Assembly
   7.10. Synthetic Microbial Consortia
   7.11. Genome Engineering
   7.12. Integrated System
8. Synthetic Biology Market – By Application
   8.1. Introduction
   8.2. Environmental Application
      8.2.1. Bioremediation
            8.2.1.1. In-Situ
            8.2.1.2. Ex-Situ
                     8.2.1.2.1. Slurry-Phase 
                     8.2.1.2.2. Solid-Phase 
      8.2.1. Whole-Cell Biosensors
   8.3. Medical Application
      8.3.1. Drug Discovery and Therapeutics
            8.3.1.1. Gene Circuits
            8.3.1.2. Delivery Platform
            8.3.1.3. Cancer Detection/Diagnostic
      8.3.2. Pharmaceuticals
      8.3.3. Artificial Tissue and Regeneration
            8.3.3.1. Bio-synthesis
            8.3.3.2. Scaffold Synthesis
            8.3.3.3. Stem Cell Regulation
            8.3.3.4. Cell Programming
   8.4. Industrial Application
      8.4.1. Biofuel and Renewable Energy
      8.4.2. Industrial Enzyme
            8.4.2.1. Textile Industry
                     8.4.2.1.1. Cellulase
                     8.4.2.1.2. Catalase
                     8.4.2.1.3. Pectinase
                     8.4.2.1.4. Alpha Amylase
            8.4.2.2. Food & Beverages
                     8.4.2.2.1. Fungal alpha Amylase
                     8.4.2.2.2. Glucoamylase
                     8.4.2.2.3. Papain enzymes
                     8.4.2.2.4. Beta glucanse
                     8.4.2.2.5. Protease
            8.4.2.3. Paper Industry
                     8.4.2.3.1. Lipases
                     8.4.2.3.2. Xylanase
            8.4.2.4. Personal Care
                     8.4.2.4.1. Carbohydrase
                     8.4.2.4.2. Isomerase
                     8.4.2.4.3. Zymase
      8.4.3. Biomaterials & Green Chemicals
            8.4.3.1. Lactic Acid
            8.4.3.2. FDCA
            8.4.3.3. Succinic Acid
            8.4.3.4. Acrylic Acid
            8.4.3.5. 1, 3 Propanediol
            8.4.3.6. Adipic Acid
            8.4.3.7. Castor-based Chemicals
9. Synthetic Biology Market - By Geography
   9.1. North America 
      9.1.1. U.S. 
      9.1.2. Canada 
      9.1.3. Ecuador Mexico 
      9.1.4. Rest of North America
   9.2. South America 
      9.2.1. Brazil 
      9.2.2. Venezuela
      9.2.3. Argentina
      9.2.4. Ecuador
      9.2.5. Peru
      9.2.6. Colombia 
      9.2.7. Costa Rica
      9.2.8. Rest of South America
   9.3. Europe 
      9.3.1. U.K 
      9.3.2. Germany 
      9.3.3. Italy 
      9.3.4. France
      9.3.5. Netherlands
      9.3.6. Belgium
      9.3.7. Spain
      9.3.8. Denmark
      9.3.9. Rest of Europe
   9.4. APAC
      9.4.1. China 
      9.4.2. Australia 
      9.4.3. South Korea
      9.4.4. India
      9.4.5. Taiwan
      9.4.6. Malaysia
      9.4.7. Hong Kong 
      9.4.8. Japan
      9.4.9. Rest of APAC
   9.5. Middle East& Africa 
      9.5.1. Israel
      9.5.2. South Africa
      9.5.3. Saudi Arabia
   9.6. Rest of Middle East and Africa
10. Market Entropy
   10.1. New Product Launches
   10.2. M&As, Collaborations, JVs, Partnership
11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   11.1. Ingenza Ltd.
   11.2. Intrexon Corp.
   11.3. Amyris Inc.
   11.4. Thermo Fisher Scientific Inc.
   11.5. Novozymes
   11.6. Cargill Inc.
   11.7. Company 7
   11.8. Company 8
   11.9. Company 9
   11.10. Company 10
   11.11. Company 11
*More than 9 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
12.Appendix
   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer

Report Details

  • Report Code:28890
  • Category:Healthcare
  • No. of Pages:140
  • Format:PDF/PPT/Excel
  • Published:August 2019
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers